Primary hyperoxaluria – Life with Disease

Go back

Primary hyperoxaluria is a rare inherited condition where the liver produces too much oxalate, a natural substance that can form crystals in the kidneys and other organs. Though symptoms often begin in childhood with kidney stones, the disease can affect many aspects of life, requiring ongoing medical care, lifestyle adjustments, and family support throughout a patient’s journey.

Understanding What Lies Ahead: Prognosis in Primary Hyperoxaluria

When someone receives a diagnosis of primary hyperoxaluria, one of the most pressing questions is what the future holds. The outlook depends heavily on which type of the disease a person has and how early it was diagnosed. Primary hyperoxaluria type 1 (PH1), the most common form accounting for about 80 percent of cases, tends to be the most severe. Kidney stones often appear anywhere from childhood to early adulthood, and the disease can progress to end-stage renal disease (ESRD)—a life-threatening condition where the kidneys can no longer filter waste from the body—at any age.[1]

For infants who show symptoms early, the prognosis is particularly concerning. Research indicates that about 50 percent of children diagnosed with primary hyperoxaluria in infancy will experience kidney failure by age 15, and approximately 80 percent will face this outcome by age 30.[5] These numbers can feel overwhelming for families, but they underscore why early detection and treatment are so important. Primary hyperoxaluria type 2 follows a similar pattern to type 1, but kidney failure typically develops later in life, offering a somewhat more favorable timeline.[1]

The natural progression varies widely even among people with the same genetic mutation. Some individuals experience frequent kidney stones and steady decline in kidney function, while others have longer periods of relative stability. This unpredictability makes it difficult to predict exactly how the disease will unfold for any particular person. What remains constant, however, is the need for vigilant monitoring and proactive management to slow disease progression as much as possible.

⚠️ Important
The age when symptoms first appear is an important indicator of disease severity. Children who develop symptoms before their first birthday face a particularly aggressive form of the disease. If you notice recurring urinary problems, blood in the urine, or failure to thrive in an infant, seeking medical evaluation promptly can make a significant difference in outcomes.

How the Disease Unfolds Without Treatment

Understanding how primary hyperoxaluria progresses naturally helps explain why treatment is so critical. The disease begins in the liver, where genetic mutations prevent certain enzymes from working properly. Without these functioning enzymes, the body produces excessive amounts of oxalate, which must be filtered out by the kidneys and expelled in urine.[1]

As oxalate levels rise in the urine, the substance combines with calcium to form calcium oxalate crystals. These hard compounds are the main building blocks of kidney stones. Early on, a person might pass small stones or experience occasional episodes of kidney pain. However, the continuous production of excess oxalate means new stones keep forming. Over time, calcium oxalate deposits don’t just create stones that move through the urinary tract—they also begin to accumulate directly in kidney tissue itself, a condition called nephrocalcinosis.[3]

The damage compounds progressively. Stones can cause urinary tract obstructions, which prevent urine from flowing properly. These blockages create opportunities for infections and cause direct injury to kidney structures. Meanwhile, calcium oxalate deposits in the kidney tissue trigger chronic inflammation. The combination of obstruction, infection, and inflammation steadily destroys the kidneys’ ability to function.

As kidney function declines, a dangerous cycle begins. When the kidneys’ filtering capacity drops below a certain threshold—typically when the glomerular filtration rate (GFR) falls below 30 to 40 milliliters per minute—they can no longer remove as much oxalate as the liver produces. Oxalate levels in the blood begin to rise dramatically, and the substance starts depositing in tissues throughout the body, a condition known as systemic oxalosis. This represents a critical turning point where a kidney disease becomes a multi-organ threat.[11]

Complications That Can Arise

Primary hyperoxaluria brings numerous complications beyond kidney stones, some of which can be life-threatening. The most immediate complications relate to the stones themselves. Each stone episode can cause severe pain, blood in the urine, urinary tract infections, and kidney damage. People with primary hyperoxaluria typically require numerous urologic procedures throughout their lives—research shows that 70 percent of patients undergo one or more surgical interventions to remove stones.[6]

Recurrent infections pose another significant risk. When stones block urine flow or when bacteria enter the urinary tract, infections can develop. These aren’t simple inconveniences—untreated or recurrent urinary tract infections can accelerate kidney damage and cause serious systemic illness. Some patients experience fever, chills, and symptoms requiring hospitalization.

Once kidney function deteriorates significantly, systemic oxalosis emerges as the most feared complication. Oxalate deposits can accumulate in bones, making them fragile and prone to fractures. In the heart, these deposits can affect the electrical system and cardiac muscle function, potentially causing life-threatening heart rhythm abnormalities. When oxalate crystals settle in the walls of blood vessels, they can cause circulation problems. The eyes can develop oxalate deposits in the retina, which may affect vision. Even nerves can be affected, causing pain or altered sensation.[1]

Kidney failure itself brings a cascade of complications. Without functioning kidneys, waste products accumulate in the blood, causing symptoms like extreme fatigue, nausea, difficulty concentrating, and fluid retention. Patients require dialysis to stay alive, but standard dialysis cannot keep up with the continuous oxalate production in primary hyperoxaluria, making this a particularly challenging situation.[3]

Impact on Daily Life

Living with primary hyperoxaluria affects virtually every aspect of daily existence. The most immediate daily burden is the need for hyperhydration—drinking extraordinary amounts of water. This isn’t about having a few extra glasses of water; patients often need to consume two to three liters or more every single day to dilute the oxalate in their urine and reduce crystal formation.[18]

This level of fluid intake creates constant disruptions. Children miss parts of classes to use the bathroom. Adults struggle to maintain focus at work when they must excuse themselves frequently. Social situations become complicated when you need access to restrooms at all times. Sleep is fragmented because the bladder fills repeatedly during the night. For young children who cannot manage this fluid intake on their own, some require a feeding tube surgically placed in the stomach to ensure adequate hydration throughout the day and night.[13]

Beyond hydration, the unpredictability of stone episodes casts a shadow over planning. A kidney stone attack can strike without warning, bringing excruciating pain that makes normal activities impossible. Families miss vacations, students miss school, and employees miss work. The fear of when the next episode might occur creates ongoing anxiety. One parent described the daily challenge: “It is a daily challenge to make sure our son is drinking constantly throughout the day. As a 12-year-old, he misses sleepovers, sleep away camp, and overnight school trips.”[21]

The emotional toll is substantial. Many people with primary hyperoxaluria experience symptoms of anxiety and depression, particularly those with advanced kidney disease. The invisible nature of the condition means others cannot see the struggle, which can lead to feelings of isolation. Children and teenagers may feel different from their peers, struggling to explain why they can’t participate in certain activities or why they always need to be near a bathroom.

Physically, the disease limits activities in various ways. Patients must be cautious about situations that could cause dehydration—intense exercise, hot weather, or illnesses involving vomiting or diarrhea all pose risks. Travel requires careful planning to ensure adequate fluid intake and access to medical care. For those who have progressed to kidney failure, the time commitment for dialysis treatments—often several hours, multiple times per week—becomes all-consuming.

Financial strain adds another layer of difficulty. The costs associated with frequent medical visits, imaging studies, procedures to remove stones, medications, and potentially transplantation can be overwhelming. Even with insurance, copayments and deductibles accumulate. Some families face difficult decisions about treatment options based on financial considerations.[21]

⚠️ Important
Managing the emotional aspects of primary hyperoxaluria is just as important as managing the physical disease. If you or your loved one feels overwhelmed, anxious, or depressed, speak with your healthcare team about connecting with a mental health professional. Support groups connecting families affected by primary hyperoxaluria can also provide valuable emotional support and practical advice from those who truly understand the challenges.

Supporting Families Through Clinical Trials

For families affected by primary hyperoxaluria, clinical trials represent hope for better treatments and potentially a cure. Understanding what clinical trials involve and how to support a loved one through participation is important for family members who want to help.

Clinical trials are research studies that test new treatments, medications, or procedures to determine if they are safe and effective. In primary hyperoxaluria, recent years have seen promising developments in treatments based on RNA interference technology that can reduce oxalate production in the liver. Participating in such trials may give patients access to cutting-edge therapies before they become widely available.[9]

Family members can help by researching available trials appropriate for their loved one’s situation. Various organizations, including patient advocacy groups and kidney disease networks, maintain directories of ongoing clinical trials for primary hyperoxaluria. Understanding the eligibility criteria, potential benefits, and possible risks helps families make informed decisions about whether participation might be appropriate.

Supporting someone through trial participation means being present for appointments, helping track symptoms or side effects, and providing emotional encouragement. Clinical trials often require frequent visits, additional testing, and careful documentation of how the patient is feeling. Family members can assist with transportation, help remember questions to ask the research team, and take notes during appointments when the patient might feel overwhelmed by information.

It’s also important for families to understand that not everyone who wants to participate in a trial will be eligible, and not all trials will show positive results. Helping maintain realistic expectations while remaining hopeful is a delicate balance. Some families find it helpful to connect with other families who have participated in trials to learn from their experiences.

Relatives can also assist with practical preparations. If a trial requires travel to a specialized center, family members might help arrange accommodations, manage work schedules to allow time off, or coordinate care for other family members. For children participating in trials, parents need to understand how to explain what’s happening in age-appropriate ways and provide extra reassurance during new procedures or tests.

Beyond individual trial participation, families can support research more broadly by contributing to patient registries, sharing their experiences with researchers who are studying the impact of the disease, and raising awareness about primary hyperoxaluria. These activities help advance understanding of the disease even if direct trial participation isn’t possible.

💊 Registered drugs used for this disease

List of officially registered medicines that are used in the treatment of this condition, based only on the provided sources:

  • Lumasiran (Oxlumo) – An RNA interference therapeutic that reduces oxalate production by targeting and degrading the messenger RNA of glycolate oxidase enzyme in the liver, helping to lower urinary and plasma oxalate levels in primary hyperoxaluria type 1.
  • Nedosiran (Rivfloza) – An RNA interference drug that blocks liver-specific lactate dehydrogenase A enzyme to reduce oxalate production in primary hyperoxaluria.
  • Pyridoxine (Vitamin B6) – When taken in prescription-level doses, this vitamin can significantly reduce urinary oxalate excretion in some patients with specific missense AGXT gene variants that are pyridoxine-responsive.
  • Potassium citrate – A salt that forms complexes with calcium in urine, making oxalate stones less likely to form by preventing calcium oxalate crystal aggregation.

Ongoing Clinical Trials on Primary hyperoxaluria

  • Study on the Safety and Effects of ABO-101 with mRNA-002 and gRNA-001 for Patients with Primary Hyperoxaluria Type 1

    Recruiting

    1 1
    Investigated diseases:
    Investigated drugs:
    France Germany The Netherlands
  • Study on Stiripentol for Patients Aged 6 and Older with Primary Hyperoxaluria Types 1, 2, or 3

    Not yet recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Belgium France Italy

References

https://medlineplus.gov/genetics/condition/primary-hyperoxaluria/

https://www.kidney.org/kidney-topics/primary-hyperoxaluria-type-1

https://www.ncbi.nlm.nih.gov/books/NBK1283/

https://www.kidneyfund.org/all-about-kidneys/other-kidney-diseases/primary-hyperoxaluria-and-oxalate-symptoms-causes-and-treatment

https://my.clevelandclinic.org/health/diseases/21117-hyperoxaluria

https://www.uncoveringph.com/

https://www.mayoclinic.org/diseases-conditions/hyperoxaluria/symptoms-causes/syc-20352254

https://www.childrenshospital.org/conditions/primary-hyperoxaluria-ph

https://pmc.ncbi.nlm.nih.gov/articles/PMC9329168/

https://my.clevelandclinic.org/health/diseases/21117-hyperoxaluria

https://www.nature.com/articles/s41581-022-00661-1

https://www.mayoclinic.org/diseases-conditions/hyperoxaluria/diagnosis-treatment/drc-20352258

https://www.webmd.com/kidney-stones/primary-hyperoxaluria-type-1-treat

https://emedicine.medscape.com/article/444683-overview

https://www.ema.europa.eu/en/news/first-treatment-rare-condition-primary-hyperoxaluria-type-1

https://www.kidney.org/kidney-topics/primary-hyperoxaluria-type-1

https://ohf.org/living-with-hyperoxaluria/

https://www.webmd.com/kidney-stones/primary-hyperoxaluria-type-1-life

https://www.livingwithph1.eu/living-with-primary-hyperoxaluria-type-1

https://www.kidney.org/kidney-topics/primary-hyperoxaluria-type-1

https://pmc.ncbi.nlm.nih.gov/articles/PMC7341774/

https://takeonph1.com/living-with-primary-hyperoxaluria-type-1

https://www.understandingph.com/managing-ph.html

https://www.kidneyfund.org/all-about-kidneys/other-kidney-diseases/primary-hyperoxaluria-and-oxalate-symptoms-causes-and-treatment

https://www.nature.com/articles/s41581-022-00661-1

https://www.novonordisk-us.com/disease-areas/primary-hyperoxaluria.html

https://medlineplus.gov/diagnostictests.html

https://www.questdiagnostics.com/

https://www.healthdirect.gov.au/diagnostic-tests

https://www.who.int/health-topics/diagnostics

https://www.yalemedicine.org/clinical-keywords/diagnostic-testsprocedures

https://www.nibib.nih.gov/science-education/science-topics/rapid-diagnostics

https://www.health.harvard.edu/diagnostic-tests-and-medical-procedures

https://www.roche.com/stories/terminology-in-diagnostics

FAQ

How is primary hyperoxaluria different from having kidney stones?

Primary hyperoxaluria is a genetic disease where the liver continuously produces too much oxalate, leading to recurring kidney stones throughout life. Regular kidney stones can occur from dietary factors or other causes in people without this genetic condition. In primary hyperoxaluria, stones keep forming no matter how careful someone is with their diet because the problem originates in the liver’s metabolism.

Can primary hyperoxaluria be passed to children?

Yes, primary hyperoxaluria is inherited in an autosomal recessive pattern. This means both parents must carry one copy of the mutated gene to have a child with the disease. Parents who carry one copy typically don’t show symptoms themselves. If both parents are carriers, each child has a 25 percent chance of inheriting the disease, a 50 percent chance of being a carrier, and a 25 percent chance of inheriting neither mutation.

Why do some patients need both a liver AND kidney transplant?

The liver is where the defective enzyme causes oxalate overproduction, so a liver transplant provides the normal enzyme needed to stop making excess oxalate. However, by the time many patients reach the point of needing a liver transplant, their kidneys have already been severely damaged by years of oxalate buildup. A kidney transplant addresses the existing kidney failure. Some patients receive both organs simultaneously, while others may have them done sequentially.

Is there a special diet for primary hyperoxaluria?

Unlike some kidney conditions, primary hyperoxaluria isn’t primarily caused by diet, so there’s no specific “hyperoxaluria diet.” However, some experts suggest limiting foods very high in oxalate (like spinach, nuts, chocolate, and star fruit). More importantly, patients must drink large amounts of water daily. Calcium intake should not be restricted and may actually help by binding to oxalate in the intestines. Always consult with your healthcare team before making dietary changes.

Are the new RNA interference medications a cure?

RNA interference medications like lumasiran and nedosiran are not cures, but they represent significant advances in treatment. These medications can reduce or even normalize oxalate levels in many patients by interfering with the liver’s oxalate production. However, patients must continue taking them regularly to maintain the effect. The only current cure for primary hyperoxaluria type 1 is a liver transplant that provides normally functioning enzymes.

🎯 Key takeaways

  • Primary hyperoxaluria originates in the liver but primarily damages the kidneys, creating a unique treatment challenge that sometimes requires transplanting both organs.
  • Children diagnosed in infancy face particularly aggressive disease, with about 50% experiencing kidney failure by age 15.
  • The daily requirement to drink enormous amounts of water—often 2-3 liters or more—affects sleep, school, work, and social activities profoundly.
  • When kidneys fail in primary hyperoxaluria, oxalate begins depositing throughout the body in bones, heart, blood vessels, and eyes—a life-threatening condition called systemic oxalosis.
  • New RNA interference medications can now reduce oxalate production in the liver, offering hope for preventing progression without requiring transplantation in some patients.
  • Seventy percent of primary hyperoxaluria patients will undergo at least one surgical procedure to remove kidney stones during their lifetime.
  • The disease affects fewer than 1,000 diagnosed Americans, but genetic studies suggest many more people carry the mutations unknowingly.
  • Family genetic testing is recommended after one member receives a primary hyperoxaluria diagnosis, as siblings share the same inheritance pattern risk.